ASMI welcomes Complementary Medicines Review

23 February 2015

Return to Media Release Index

23 February 2015 - The Australian Self Medication Industry (ASMI) today welcomed the Federal Government's Review of complementary medicines.
ASMI Executive Director, Dr Deon Schoombie, said: "This is a great opportunity to get the right regulatory settings for complementary medicines, which are taken by 70% of Australians.

"ASMI urges the Federal Government to apply the COAG principle of 'minimum effective regulation' to the regulation of low risk medicines such as complementary medicines, while maintaining appropriate safety standards for consumers.
"ASMI believes there are a range of areas that would benefit from regulatory reform, including for example, policy relating to new ingredients, Good Manufacturing Practice and advertising, amongst others.

"The Therapeutic Goods Administration (TGA) should accept low risk ingredients approved by comparable overseas regulators as part of streamlining new ingredient approvals and increasing access for consumers.

"ASMI supports the maintenance of Good Manufacturing Practice principles but urges the TGA to provide clearer guidance materials for lowest-risk products and align clearance frequency with overseas agency audits.
"ASMI advocates for an improved system for pre approving advertising and complaints handling.
"ASMI looks forward to providing a detailed submission covering a range of regulatory reform proposals that will ensure the right settings for Australia's complementary medicines regulatory framework," he added.
-ENDS-

About ASMI: The Australian Self Medication Industry (ASMI) is the peak body representing sponsors of non-prescription medicines - over-the-counter (OTC) and complementary medicines (CM). ASMI members make up 85 per cent of the $4bn Non-Prescription Medicines market. Membership totals 50 companies and ASMI members employ approximately 18,000 people with exports estimated at $1.2 billion annually. ASMI's mission is to advance consumer health through responsible self-care. This means driving a viable and responsible industry and empowering the consumer with evidence-based products and information with the aim of improving health and wellbeing. To find out more about ASMI or how to become an ASMI member, please visit (www.asmi.com.au).

For more information or to arrange a media interview, please contact:
Marie Kelly-Davies
Communications Manager, Australian Self Medication Industry (ASMI)
M:0408 256 381 E: marie@asmi.com.au